Israeli biotech Brainstorm has received a US patent for its autologous stem cell technology for the treatment of neuro-degenerative diseases. Brainstorm is preparing for its US upcoming multi-center Phase II trial with its proprietary NurOwn stem cell therapy.
http://www.brainstorm-cell.com/index.php/news-a-events/291-march-24-2014